Service Agreements
Find out more about our Service Agreements here.
Features of our pharmaceutical isolators & barrier systems
Our barrier systems include open RABS, closed RABS, isolators, and containment systems. They all offer you maximum flexibility for a broad range of applications, protecting products and personnel in the best possible way. While our RABS enhance the quality of everyday multi-product manufacturing in existing cleanrooms, our isolators further boost the safety of filling lines for high potent medications.
Benefits:
- Safe filling of aspectic, BSL and highly potent products
- Qualification and validation support including cycle development
- Intensive research for RABS, isolator and related barrier technologies
Use case scenarios
Glove testing systems
The highest safety for isolators and RABS
Maintaining an aseptic production
How to transfer products into barrier systems
A challenge for sterile manufacturing
How will Annex 1 change fill/finish processes?
Syntegon and AbbVie
Taking ADC processing to the next level
RABS vs. Isolator
Choosing the right isolation technology
Aseptic and highly potent drugs
Insights into state-of-the-art sterile fill/finish applications
Digital Solutions
Find out more about Digital Solutions here.
Parts
Find out more about Parts here.
Maintenance
Find out more about Maintenance here.
/remote-assistant.jpg?width=640&height=380&name=remote-assistant.jpg)
Technical Support
Find out more about Technical Support here.
Modernizations
Find out more about Modernizations here.
Training
Find out more about our Training here.
Expert Services
Find out more about our Expert Services here.
Our experts behind the scenes
„In line with our philosophy, the integration of air handling into filling line isolators is a major step in minimizing on-site complexity for our customers.
Our goal is to provide solutions that make our customers´ lives easier by reducing interfaces and maximizing integration.”
Lukas Munzinger - Global Product Manager Isolator Technology
Our experts behind the scenes
“An isolator is the most consistent answer for the most stringent quality requirements in parenteral filling. Mechanics, electrics and software must all be tuned perfectly to achieve the process performance for which Syntegon isolators are known today. The expectations of our customers motivates us to deliver maximum performance!”
Dr. Johannes Rauschnabel – Head of advanced development packaging technology and chief pharma expert
Our experts behind the scenes
“For the past 20-plus years and counting, I have associated Syntegon isolators with highest process reliability, the most stringent pharmaceutical requirements, and ultimately – the lives of millions of patients impacted worldwide.”
Mathias Kreher – Sales
Our experts behind the scenes
“With Syntegon isolators I associate short and efficient cycle times for biodecontamination.”
Annika Klenk – Project manager cycle development/validation
Our experts behind the scenes
“Working with Syntegon isolators and their cycle development requires close coordination with our customers. The interesting discussions that result from this are very valuable because they further develop us as well as our customers.”
Carmen Riedt – Group leader and responsible for qualification
Our experts behind the scenes
“With Syntegon isolators, I associate a great collaboration, internally as well as with many different teams from our customers.”
Michael Meyer – Team leader cycle development/validationand process development
https://www.syntegon.com/hubfs/05_website/Content/1-Solutions/1-Pharma/1-Technology-pages/24-Barrier-Systems-and-Containment/Isolator_Brochure_EN_low.pdf|Isolator_brochure_EN_low
https://www.syntegon.com/hubfs/05_website/Content/1-Solutions/1-Pharma/1-Technology-pages/24-Barrier-Systems-and-Containment/Syntegon_Strategies-for-barrier-system-BSL.pdf|Isolator_Strategies-for-barrier-system-BSL
https://www.syntegon.com/hubfs/05_website/Content/1-Solutions/1-Pharma/1-Technology-pages/24-Barrier-Systems-and-Containment/Whitepaper_Syntegon_Merck_Avoiding-product-oxidation.pdf|Isolator_whitepaper_oxidation
https://www.syntegon.com/hubfs/05_website/Content/1-Solutions/1-Pharma/1-Technology-pages/24-Barrier-Systems-and-Containment/Whitepaper_Syntegon_H2O2-biodecontamination-cycle-times.pdf|Isolator_whitepaper_biodecontamination
-1-1.jpeg?width=270&height=152&name=Technologies_Isolator_techn_Short_cycle_times_for_biodecontamination_2%20(1)-1-1.jpeg)
Pharmaceutical isolator downloads
Isolator Systems
Safety and performance from one source.
Whitepaper
How to design an isolated fill / finish process that protects both products and operators.
Whitepaper
Avoiding product oxidation by H2O2 in isolators.
Whitepaper
The past, present and future of H2O2 biodecontamination cycle times.
Read our latest pharma news
14.08.2025
Confidently scaling cell and gene therapies
Learn about the promise of cell and gene therapies and the urgent need for automation to tackle rising development costs in the pharmaceutical industry.
FCE Pharma: Prazer em conhecê-lo
Join us at FCE Pharma, Latin America's largest pharmaceutical event! Visit Syntegon at booth C-80...
Smart solutions for efficient vaccine manufacturing
Discover Syntegon, a leader in vaccine manufacturing equipment with over 30 years of experience and...
Pharmatag 2025: Let’s shape the pharmaceutical future together
Join us at Pharmatag 2025 in Crailsheim, Germany, and experience how co-creation revolutionizes...
Syntegon enhances inspection portfolio with RTU handling equipment
Stay informed about the booming RTU syringe market and Syntegon's AIM DIRect, featuring...